Terbinafine Hydrochloride

CAS 78628-80-5 23 current records 7 historicalSmall Molecule

Who holds supplier records for Terbinafine Hydrochloride? 23 organisations hold a current record for Terbinafine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 19 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), China (4), Israel (1), Malta (1) and 5 other countries (5); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Terbinafine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/terbinafine-hydrochloride

Reading the evidence

  • 23 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 14 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (23)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Terbinafine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Terbinafine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (19)

Certificates of Suitability on the EDQM register for Terbinafine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2025-079 - Rev 00
Terbinafine hydrochloride
Nov 2026—
ORBION PHARMACEUTICALS PRIVATE LIMITED IrungattukottaiIN
CEP 2023-378 - Rev 00
Terbinafine hydrochloride
Oct 2026Inspected Aug 2024
Germany
CIPLA LIMITED MumbaiIN
CEP 2007-028 - Rev 06
Terbinafine hydrochloride
Aug 2026—
OLON S.P.A. RodanoIT
CEP 2021-256 - Rev 03
Terbinafine hydrochloride, Type 2
Jul 2026Inspected Mar 2025
Italy
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2009-008 - Rev 04
Terbinafine hydrochloride
Jul 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2007-316 - Rev 05
Terbinafine hydrochloride
May 2026—
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2012-269 - Rev 02
Terbinafine hydrochloride
Nov 2025Inspected Apr 2025
Spain
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2024-501 - Rev 01
Terbinafine hydrochloride, Process 2, Micronised, non-micronised
Oct 2025Inspected Nov 2025
Greece
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan CityCN
CEP 2024-205 - Rev 00
Terbinafine hydrochloride
Sept 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2007-146 - Rev 08
Terbinafine hydrochloride
Aug 2025—
Amino Chemicals LTD. MarsaMT
CEP 2024-280 - Rev 00
Terbinafine hydrochloride, Catalyst 2
Sept 2024Inspected Nov 2024
Malta
HETERO LABS LIMITED HyderabadIN
CEP 2012-310 - Rev 03
Terbinafine hydrochloride, Process II
Sept 2024—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2017-102 - Rev 02
Terbinafine hydrochloride
Apr 2024—
SAPTAGIR LABORATORIES PVT LTD. HyderabadIN
R0-CEP 2020-409 - Rev 00
Terbinafine hydrochloride
May 2023—
SYNERGENE ACTIVE INGREDIENTS PVT. LIMITED HyderabadIN
R0-CEP 2022-305 - Rev 00
Terbinafine hydrochloride, Unit-II
Nov 2022—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
R1-CEP 2006-157 - Rev 04
Terbinafine hydrochloride
Aug 2019—
CHR. OLESEN SYNTHESIS A/S HvidovreDK
R1-CEP 2010-156 - Rev 02
Terbinafine hydrochloride
May 2019—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2006-112 - Rev 02
Terbinafine hydrochloride
Jan 2019—
Zhejiang East-Asia Pharmaceutical Co., Ltd. PubagangCN
R1-CEP 2010-006 - Rev 01
Terbinafine hydrochloride
Nov 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Terbinafine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • China · Inactive DMF 21717 · filed Jun 2008
  • Italy · Inactive DMF 20266 · filed Jan 2007
  • India · Inactive DMF 19775 · filed Sept 2006
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 18758 · filed Sept 2005
  • MYLAN LABORATORIES LTD
    Inactive DMF 18224 · filed Mar 2005
  • RECORDATI ESPANA SL
    Inactive DMF 17291 · filed Mar 2004
  • PERRIGO API LTD
    Inactive DMF 16784 · filed Aug 2003

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Terbinafine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200832).

Chemical identity

IUPAC name
(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine;hydrochloride
Canonical SMILES
CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21.Cl
InChIKey
BWMISRWJRUSYEX-SZKNIZGXSA-N
Synonyms
Athlete's foot, Bramazil, Bramizil, Lamisil, Lamisil at, Lamisil once, Muzonal, NSC-759113, Terbina, Terbinafine (as hydrochloride), Terbinafine hcl, Terbinafine hydrochloride

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Allylamine Antifungal
Chemical structure
Allylamine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Terbinafine Hydrochloride?

23 organisations hold an active US FDA Type II Drug Master File or a CEP for Terbinafine Hydrochloride: ALIVUS LIFE SCIENCES LTD (India), Taro Pharmaceutical Industries Ltd. (Israel), Amino Chemicals Ltd (Malta), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India) and Gedeon Richter (Hungary), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Terbinafine Hydrochloride Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 21229, 18175), Taro Pharmaceutical Industries Ltd. (DMF 17790, 30940), Amino Chemicals Ltd (DMF 16283), APITORIA PHARMA PRIVATE LTD (DMF 18192), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 31719), Cipla Limited (DMF 17330), Dr. Reddy's Laboratories Ltd. (DMF 15887) and Gedeon Richter (DMF 16511) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Terbinafine Hydrochloride records mean?

7 organisations have only inactive Type II DMFs for Terbinafine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Terbinafine Hydrochloride have a European Certificate of Suitability?

Yes. 19 organisations hold a valid CEP for Terbinafine Hydrochloride on the EDQM register, including IPCA LABORATORIES LIMITED Mumbai (IN), ORBION PHARMACEUTICALS PRIVATE LIMITED Irungattukottai (IN), CIPLA LIMITED Mumbai (IN), OLON S.P.A. Rodano (IT), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and ALIVUS LIFE SCIENCES LIMITED Mumbai (IN) and 13 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Terbinafine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Terbinafine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.